🔎 Trials Near Me

Home › Cystic Fibrosis › NCT07048574

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

RecruitingObservational study

Who can join

18 Months – 11 Years · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Child with a diagnosis of Cystic fibrosis (CF) actively followed by the CF care team at a participating site
2. Child is age 18 months thru 11 years
3. English and/or Spanish speaking
4. Parent/legal guardian willing and able to give informed consent, and for minor participants ages 7 thru 11 years able to give assent.

Exclusion Criteria:

* Unable or unwilling to participate in study procedures, or at Site PI discretion.

About the study

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

Sponsor: State University of New York at Buffalo · Participants: 600 · Started: Jun 2, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07048574

Locations in the U.S.

CaliforniaChildren's Hospital of Orange County, Orange
ColoradoChildren's Hospital Colorado, Aurora
FloridaJoe DiMaggio, Hollywood
Nemours Foundation, Orlando
IndianaIndiana University, Bloomington
MassachusettsMassachusetts General Hospital, Boston
New YorkUniversity at Buffalo, Buffalo
North CarolinaUniversity of North Carolina School of Medicine, Chapel Hill
OhioCincinnati Children's Hospital Medical Center, Cincinnati
TexasUT Southwestern, Plano
VirginiaChildren's Hospital of Richmond at Virginia Commonwealth University, Richmond
WashingtonSeattle Children's Hospital, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.